Lauren C Harshman Selected Research

Lauren C Harshman Research Topics

Disease

37	Neoplasms (Cancer) 01/2023 - 01/2009
36	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 12/2007
18	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 08/2013
15	Neoplasm Metastasis (Metastasis) 03/2024 - 05/2014
14	Carcinoma (Carcinomatosis) 12/2021 - 01/2009
10	Urinary Bladder Neoplasms (Bladder Cancer) 12/2020 - 08/2014
3	Kidney Neoplasms (Kidney Cancer) 01/2023 - 11/2017
3	Disease Progression 01/2021 - 01/2009
3	Fatigue 01/2020 - 06/2018
3	Melanoma (Melanoma, Malignant) 01/2017 - 08/2014
2	Inflammation (Inflammations) 12/2020 - 06/2014
2	Urologic Neoplasms (Urological Cancer) 10/2020 - 10/2019
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2014 - 05/2014
1	Brain Neoplasms (Brain Tumor) 12/2021
1	Adenocarcinoma 10/2019
1	Residual Neoplasm 10/2019
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2019
1	Pathologic Complete Response 01/2019
1	Lymphatic Metastasis 01/2019
1	Vasculitis (Vasculitides) 01/2019
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2019
1	Venous Thromboembolism 10/2017
1	Hematologic Neoplasms (Hematological Malignancy) 01/2017

Drug/Important Bio-Agent (IBA)

11	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2017
9	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2009
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2018 - 10/2009
8	AndrogensIBA 01/2021 - 08/2013
6	PlatinumIBA 12/2021 - 01/2009
6	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 05/2014
6	Hormones (Hormone)IBA 12/2020 - 09/2010
4	Bevacizumab (Avastin)FDA Link 01/2023 - 10/2010
4	cabozantinibIBA 12/2021 - 06/2018
4	Abiraterone AcetateIBA 01/2021 - 08/2013
4	B7-H1 AntigenIBA 01/2021 - 07/2014
4	Docetaxel (Taxotere)FDA Link 12/2020 - 01/2009
4	Hemoglobins (Hemoglobin)IBA 11/2018 - 10/2009
4	Prostate-Specific Antigen (Semenogelase)IBA 11/2018 - 06/2014
3	atezolizumabIBA 01/2023 - 01/2020
3	CytokinesIBA 12/2020 - 06/2014
3	Androgen Receptors (Androgen Receptor)IBA 12/2020 - 11/2017
3	abirateroneIBA 10/2019 - 08/2013
3	Sunitinib (Sutent)FDA Link 11/2018 - 06/2009
2	Radium-223IBA 03/2024 - 01/2018
2	pembrolizumabIBA 03/2024 - 01/2019
2	Prednisone (Sone)FDA LinkGeneric 01/2021 - 10/2019
2	IpilimumabIBA 12/2020 - 08/2014
2	enzalutamideIBA 12/2020 - 10/2019
2	Interleukin-8 (Interleukin 8)IBA 12/2020 - 06/2014
2	Proteins (Proteins, Gene)FDA Link 11/2020 - 06/2014
2	Cell-Free Nucleic AcidsIBA 11/2018 - 11/2017
2	pazopanib FDA Link 11/2018 - 01/2018
2	Everolimus FDA Link 01/2018 - 06/2013
2	LigandsIBA 01/2018 - 07/2014
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2017 - 07/2015
2	Monoclonal AntibodiesIBA 01/2017 - 08/2014
2	thiamine triphosphorate (TTP)IBA 02/2016 - 07/2015
2	Gemcitabine FDA Link 08/2015 - 12/2010
2	TOR Serine-Threonine KinasesIBA 10/2014 - 06/2013
2	Tyrosine Kinase InhibitorsIBA 04/2013 - 02/2013
1	sacituzumab govitecanIBA 12/2021
1	enfortumab vedotinIBA 12/2021
1	erdafitinibIBA 12/2021
1	Bone Density Conservation AgentsIBA 01/2021
1	NivolumabIBA 12/2020
1	CrizotinibIBA 12/2020
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 11/2020
1	5'-Nucleotidase (5' Nucleotidase)IBA 11/2020
1	CD39 antigenIBA 11/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	NucleotidesIBA 01/2020
1	taxaneIBA 01/2020
1	Therapeutic UsesIBA 10/2019
1	Leuprolide (Lupron)FDA LinkGeneric 10/2019
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 10/2019
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2019
1	Alkaline PhosphataseIBA 11/2018
1	TFXIBA 11/2018
1	Sorafenib (BAY 43-9006)FDA Link 11/2018
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 11/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	Tyrosine (L-Tyrosine)FDA Link 01/2018
1	Radioisotopes (Radionuclides)IBA 11/2017
1	Interleukin-2 (IL2)IBA 11/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2015

Therapy/Procedure

42	Therapeutics 01/2023 - 01/2009
12	Drug Therapy (Chemotherapy) 12/2021 - 08/2013
11	Castration 03/2024 - 08/2013
7	Immunotherapy 01/2023 - 08/2014
7	Cystectomy 12/2020 - 08/2015
4	Adjuvant Chemotherapy 12/2020 - 01/2018
4	Nephrectomy 11/2018 - 12/2007
3	Neoadjuvant Therapy 10/2020 - 08/2015
3	Chemoradiotherapy 04/2018 - 12/2014
2	Combination Drug Therapy (Combination Chemotherapy) 12/2021 - 10/2019
2	Drug Tapering 01/2020 - 06/2018
1	Urinary Diversion (Ileal Conduit) 12/2020
1	Prostatectomy (Retropubic Prostatectomy) 10/2019
1	Lymph Node Excision (Lymph Node Dissection) 01/2019
1	Re-Irradiation 04/2017
1	Radiotherapy 04/2017